The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

The continued pressure of COVID-19 on public health worldwide underlines the need for a
better understanding of the mechanisms of disease caused by severe acute respiratory …

Monoclonal antibodies (mAbs) targeting the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) spike protein have demonstrated clinical efficacy in preventing or treating …

Symptom propagation occurs when the symptom set an individual experiences is correlated
with the symptom set of the individual who infected them. Symptom propagation may …

Background: Significant evidence suggests that SARS-CoV-2 can be transmitted via
respiratory aerosols, which are known to vary as a function of respiratory activity. Most …

Emergence of the betacoronavirus SARS-CoV-2 has resulted in a historic pandemic, with
millions of deaths worldwide. An unprecedented effort has been made by the medical …

Background: As the COVID-19 pandemic has progressed, numerous variants of SARS-CoV-
2 have arisen, with several displaying increased transmissibility. Methods: The present study …

Nonhuman primate models are essential for the development of vaccines and antivirals
against infectious diseases. Rhesus macaques are a widely utilized infection model for …

Despite uncertainty about the specific transmission risk posed by airborne, spray-borne, and
contact modes for influenza, SARS-CoV-2, and other respiratory viruses, there is evidence …